7.56
price down icon0.66%   -0.05
after-market Dopo l'orario di chiusura: 7.56
loading
Precedente Chiudi:
$7.61
Aprire:
$7.6
Volume 24 ore:
454.39K
Relative Volume:
1.48
Capitalizzazione di mercato:
$171.33M
Reddito:
$52.55M
Utile/perdita netta:
$-23.69M
Rapporto P/E:
-8.0426
EPS:
-0.94
Flusso di cassa netto:
$-15.29M
1 W Prestazione:
-10.74%
1M Prestazione:
-36.79%
6M Prestazione:
+14.55%
1 anno Prestazione:
+84.39%
Intervallo 1D:
Value
$7.45
$7.645
Intervallo di 1 settimana:
Value
$7.45
$8.55
Portata 52W:
Value
$2.76
$12.23

Exagen Inc Stock (XGN) Company Profile

Name
Nome
Exagen Inc
Name
Telefono
(760) 560-1501
Name
Indirizzo
1261 LIBERTY WAY, VISTA, CA
Name
Dipendente
209
Name
Cinguettio
@ExagenInc
Name
Prossima data di guadagno
2025-03-11
Name
Ultimi documenti SEC
Name
XGN's Discussions on Twitter

Confronta XGN con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Diagnostics & Research icon
XGN
Exagen Inc
7.56 172.47M 52.55M -23.69M -15.29M -0.94
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
586.07 220.72B 43.74B 6.58B 6.11B 17.31
Diagnostics & Research icon
DHR
Danaher Corp
226.98 160.62B 24.27B 3.50B 5.02B 4.8589
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
752.14 57.96B 4.17B 1.03B 940.22M 12.61
Diagnostics & Research icon
A
Agilent Technologies Inc
153.60 42.88B 6.79B 1.22B 1.09B 4.2644
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
228.18 38.30B 15.90B 1.28B 2.21B 7.2842

Exagen Inc Stock (XGN) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-09-11 Iniziato B. Riley Securities Buy
2025-07-30 Aggiornamento KeyBanc Capital Markets Sector Weight → Overweight
2025-07-23 Iniziato Craig Hallum Buy
2022-08-05 Downgrade KeyBanc Capital Markets Overweight → Sector Weight
2021-10-15 Ripresa Cowen Outperform
2021-04-15 Iniziato Canaccord Genuity Buy
2020-11-10 Iniziato KeyBanc Capital Markets Overweight
2020-10-08 Iniziato BTIG Research Buy
2020-06-02 Ripresa Cantor Fitzgerald Overweight
2019-10-14 Iniziato Cantor Fitzgerald Overweight
2019-10-14 Iniziato Cowen Outperform
2019-10-14 Iniziato William Blair Outperform
Mostra tutto

Exagen Inc Borsa (XGN) Ultime notizie

pulisher
Nov 23, 2025

Why Analysts Are Updating Exagen’s Story After Higher Targets and Growth Outlook - Yahoo Finance

Nov 23, 2025
pulisher
Nov 21, 2025

Is Exagen Inc. (E08A) stock a momentum leaderMarket Sentiment Summary & Safe Entry Zone Tips - newser.com

Nov 21, 2025
pulisher
Nov 20, 2025

Is Exagen Inc. (E08A) stock protected from inflationWeekly Loss Report & Free Weekly Chart Analysis and Trade Guides - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Will Exagen Inc. stock split attract more investors2025 Growth vs Value & Daily Stock Trend Reports - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Is Exagen Inc. stock a contrarian buyProfit Target & Daily Oversold Stock Bounce Ideas - newser.com

Nov 20, 2025
pulisher
Nov 19, 2025

Why Exagen Inc. (E08A) stock stays resilient2025 Price Momentum & Target Return Focused Stock Picks - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Is Exagen Inc. (E08A) stock good for wealth creationVolume Spike & Risk Managed Trade Strategies - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Visual trend scoring systems applied to Exagen Inc.Weekly Profit Analysis & High Conviction Buy Zone Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

What to do if you’re stuck in Exagen Inc.Entry Point & Fast Moving Market Watchlists - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Short interest data insights for Exagen Inc.2025 Institutional Moves & Growth Focused Stock Pick Reports - newser.com

Nov 19, 2025
pulisher
Nov 18, 2025

How supply shortages influence Exagen Inc. (E08A) stock2025 Stock Rankings & Real-Time Chart Breakout Alerts - newser.com

Nov 18, 2025
pulisher
Nov 18, 2025

Can Exagen Inc. stock sustain revenue growth2025 Buyback Activity & Safe Capital Growth Stock Tips - newser.com

Nov 18, 2025
pulisher
Nov 18, 2025

Canaccord Genuity reiterates Buy rating on Exagen stock, maintains $15 target By Investing.com - Investing.com South Africa

Nov 18, 2025
pulisher
Nov 18, 2025

Canaccord Genuity reiterates Buy rating on Exagen stock, maintains $15 target - Investing.com India

Nov 18, 2025
pulisher
Nov 18, 2025

The Market Doesn't Like What It Sees From Exagen Inc.'s (NASDAQ:XGN) Revenues Yet As Shares Tumble 27% - simplywall.st

Nov 18, 2025
pulisher
Nov 18, 2025

Head-To-Head Analysis: EssilorLuxottica (OTCMKTS:ESLOY) and Exagen (NASDAQ:XGN) - Defense World

Nov 18, 2025
pulisher
Nov 17, 2025

Exagen (XGN) Price Target Increased by 17.39% to 15.74 - Nasdaq

Nov 17, 2025
pulisher
Nov 16, 2025

Is Exagen Inc. stock a defensive play in 2025July 2025 Summary & Reliable Volume Spike Alerts - newser.com

Nov 16, 2025
pulisher
Nov 15, 2025

How higher bond yields impact Exagen Inc. (E08A) stockPortfolio Return Report & Weekly Breakout Stock Alerts - newser.com

Nov 15, 2025
pulisher
Nov 15, 2025

Is Exagen Inc. stock attractive for long term wealth buildingWeekly Risk Report & Consistent Profit Alerts - newser.com

Nov 15, 2025
pulisher
Nov 15, 2025

How to monitor Exagen Inc. with trend dashboardsGold Moves & High Yield Equity Trading Tips - newser.com

Nov 15, 2025
pulisher
Nov 15, 2025

Exagen Inc. stock retracement – recovery analysisMarket Risk Summary & Fast Moving Market Watchlists - newser.com

Nov 15, 2025

Exagen Inc Azioni (XGN) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
diagnostics_research DGX
$190.58
price down icon 0.35%
diagnostics_research LH
$265.31
price down icon 0.12%
diagnostics_research WAT
$399.54
price up icon 1.41%
diagnostics_research MTD
$1,470.14
price up icon 1.22%
$238.58
price up icon 3.45%
diagnostics_research IQV
$228.18
price up icon 1.46%
Capitalizzazione:     |  Volume (24 ore):